(Q40577049)

21 September 2017

title

Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074. (English)

1 reference

21 September 2017

Grand EK

1

1 reference

21 September 2017

Chase AJ

2

1 reference

21 September 2017

Heath C

3

1 reference

21 September 2017

Rahemtulla A

4

1 reference

21 September 2017

Cross NC

5

1 reference

21 September 2017

publication date

1 May 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

18

1 reference

21 September 2017

issue

5

1 reference

21 September 2017

page(s)

962-966

1 reference

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403347

Overexpression of fibroblast growth factor receptor 3 in a human thyroid carcinoma cell line results in overgrowth of the confluent cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403347

Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403347

The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403347

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403347

A molecular study of the t(4;14) in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403347

The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403347

ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403347

Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403347

The FGFR1 inhibitor PD 173074 selectively and potently antagonizes FGF-2 neurotrophic and neurotropic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403347

The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403347

Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403347

A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403347

The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403347

inferred from DOI database lookup

7 January 2021

based on heuristic

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403347

inferred from DOI database lookup

7 January 2021

based on heuristic

In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403347

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2403347

1 reference

Dimensions Publication ID

21 September 2017

1053511457

0 references

1 reference